These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

517 related articles for article (PubMed ID: 23475537)

  • 1. Anti-Yo antibody-mediated paraneoplastic cerebellar degeneration in a female patient with pleural malignant mesothelioma.
    Tanriverdi O; Meydan N; Barutca S; Ozsan N; Gurel D; Veral A
    Jpn J Clin Oncol; 2013 May; 43(5):563-8. PubMed ID: 23475537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Importance of plasmapheresis in the treatment of paraneoplastic cerebellar degeneration].
    Basić-Jukić N; Kes P; Basić-Kes V; Brunetta B
    Acta Med Croatica; 2004; 58(1):63-6. PubMed ID: 15125396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Subacute cerebellar degeneration and pleural mesothelioma. Report of a case].
    Tassinari D; Sartori S; Arcangeli V; Drudi G; Panzini I; Pasini G; Ravaioli A
    Recenti Prog Med; 2000 Jun; 91(6):301-2. PubMed ID: 11512388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-Yo antibody uptake and interaction with its intracellular target antigen causes Purkinje cell death in rat cerebellar slice cultures: a possible mechanism for paraneoplastic cerebellar degeneration in humans with gynecological or breast cancers.
    Greenlee JE; Clawson SA; Hill KE; Wood B; Clardy SL; Tsunoda I; Carlson NG
    PLoS One; 2015; 10(4):e0123446. PubMed ID: 25885452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Paraneoplastic cerebellar degeneration associated with ovarian cancer: anti-Yo immunoreactivity in autoptic cerebellum and ovarian carcinoma].
    Bartos A; Stourac P; Rusina R; Sejdová M; Velenská Z
    Nervenarzt; 2002 Oct; 73(10):995-8. PubMed ID: 12376889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Paraneoplastic cerebellar degeneration--characterization of anti-Yo antibody and underlying cancer].
    Tanaka K; Tanaka M; Onodera O; Tsuji S
    Rinsho Shinkeigaku; 1995 Jul; 35(7):770-4. PubMed ID: 8777801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paraneoplastic cerebellar degeneration with anti-Yo antibodies associated with metastatic uveal melanoma.
    Valpione S; Zoccarato M; Parrozzani R; Pigozzo J; Giometto B; Laveder F; Aliberti C; Chiarion-Sileni V
    J Neurol Sci; 2013 Dec; 335(1-2):210-2. PubMed ID: 24035275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-Ri-associated paraneoplastic cerebellar degeneration. Report of a case and revision of the literature.
    Mancuso M; Orsucci D; Bacci A; Caldarazzo Ienco E; Siciliano G
    Arch Ital Biol; 2011 Sep; 149(3):318-22. PubMed ID: 22028093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paraneoplastic cerebellar degeneration with anti-Yo antibody in a patient with HER2/neu overexpressing breast cancer: a case report with a current literature review.
    Ogita S; Llaguna OH; Feldman SM; Blum R
    Breast J; 2008; 14(4):382-4. PubMed ID: 18540952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paraneoplastic cerebellar syndromes associated with antibodies against Purkinje cells.
    Schwenkenbecher P; Chacko L; Pul R; Sühs KW; Wegner F; Wurster U; Stangel M; Skripuletz T
    Int J Neurosci; 2018 Aug; 128(8):721-728. PubMed ID: 29199513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paraneoplastic neurological syndrome: patient with anti-Yo antibody and breast cancer: a case report.
    Dorn C; Knobloch C; Kupka M; Morakkabati-Spitz N; Schmolling J
    Arch Gynecol Obstet; 2003 Nov; 269(1):62-5. PubMed ID: 14605824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-Yo-associated paraneoplastic cerebellar degeneration in a man with adenocarcinoma of the gastroesophageal junction.
    Debes JD; Lagarde SM; Hulsenboom E; Sillevis Smitt PA; ten Kate FJ; Sulter GA; van Lanschot JJ
    Dig Surg; 2007; 24(5):395-7. PubMed ID: 17785986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deterioration of anti-Yo-associated paraneoplastic cerebellar degeneration.
    Finsterer J; Voigtländer T; Grisold W
    J Neurol Sci; 2011 Sep; 308(1-2):139-41. PubMed ID: 21762925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-Yo positive paraneoplastic cerebellar degeneration in the setting of cholangiocarcinoma.
    Bruhnding A; Notch D; Beard A
    J Clin Neurosci; 2017 Feb; 36():71-72. PubMed ID: 27816258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-Yo mediated paraneoplastic cerebellar degeneration in the context of breast cancer: a case report and literature review.
    Key RG; Root JC
    Psychooncology; 2013 Sep; 22(9):2152-5. PubMed ID: 23585287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-Yo antibody associated with occult fallopian tube carcinoma.
    Selby KJ; Warner J; Klempner S; Konstantinopoulos PA; Hecht JL
    Int J Gynecol Pathol; 2011 Nov; 30(6):536-8. PubMed ID: 21979588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Paraneoplastic cerebellar degeneration with bladder cancer confirmed the existence of an anti-neural antibody: a case report].
    Kawanishi K; Morita M; Nakahara K; Tetsuka S; Kouki T; Tominaga K; Endo H; Yashiro T; Tanaka K; Nakano I
    Brain Nerve; 2013 Nov; 65(11):1401-5. PubMed ID: 24200618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients.
    Shams'ili S; Grefkens J; de Leeuw B; van den Bent M; Hooijkaas H; van der Holt B; Vecht C; Sillevis Smitt P
    Brain; 2003 Jun; 126(Pt 6):1409-18. PubMed ID: 12764061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Paraneoplastic neurologic degeneration revealing ovarian cancer recurrence].
    Zouiten O; Benbrahim Z; Amaadour L; Mellas N
    Pan Afr Med J; 2019; 33():281. PubMed ID: 31692829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-Yo antibody-mediated paraneoplastic cerebellar degeneration in a man with esophageal adenocarcinoma.
    Xia K; Saltzman JR; Carr-Locke DL
    MedGenMed; 2003 Aug; 5(3):18. PubMed ID: 14600654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.